Rumored iWatch Supplier TPK's Q3 Forecast Falls Flat Amid Reports of Production Issues
Details discussed during a recent earnings conference call by Apple supplier TPK Holdings suggest the production of the iWatch is behind schedule, reports UDN via GforGames. According to earlier rumors, the iWatch may debut in late 2014 with the latest report claiming it will launch alongside the 5.5-inch iPhone 6.
Based on reports from Asian sources, TPK executives spent a portion of the company's Q3 2014 earning conference call explaining why it sees poorer than expected financial projections for the current quarter. TPK is allegedly supplying Apple with flexible displays that use silver nanowire touch screen technology for inclusion in the iWatch wearable.
Though the iWatch was not mentioned in the call, pundits believe TPK's shortfall is the result of a slip in the production schedule for the iWatch, which had been expected to be in production and contributing to TPK's bottom line during the third quarter. Now, the company is projecting an increase in profits during Q4 2014, suggesting the iWatch rollout may be slated for closer to the end of this year.
Shares of TPK stock dropped significantly late last week on the outlook.
At an investor conference Thursday, TPK forecast flat quarterly growth, or at best a 5 percent sequential increase, of its consolidated sales for the third quarter, citing decisions by its customers to postpone the launch of their new products. [...]
Sales growth, however, could pick up in September, TPK said, forecasting a break-even operating margin in the third quarter on higher operating costs.
This late start in production may result in Apple shipping fewer iWatch units than expected in 2014, claims analysts at CSLA, a leading Asian investment banking and asset management firm. Instead of shipping 20 million iWatch units by the end of the year, Apple may only be able to deliver a significantly smaller 6 million units. It is unknown if this lowered estimate will translate into a shortage of the device at launch.
Popular Stories
Bloomberg's Mark Gurman has high expectations for Apple's first foldable iPhone.
In his Power On newsletter today, he said the foldable iPhone will be "the most significant overhaul in the iPhone's history."
"iPhone 4, iPhone 6 and iPhone X were clearly a big deal, but this is a whole new design," he said.
Like Samsung's Galaxy Z Fold 7, the foldable iPhone will reportedly open up like ...
iOS 26.5 is now available for developers, and while it doesn't include any new Siri capabilities, there are some major changes for the European Union, and smaller tweaks for features available worldwide.
Suggested Places
In the Maps app, there's a new "Suggested Places" feature that recommends locations to visit based on trending places nearby and recent searches. When Apple launches ads in ...
Apple has been celebrating its upcoming 50th anniversary by hosting surprise performances and other events around the world over the past few weeks, and now Bloomberg's Mark Gurman has revealed details about the company's grand finale.
In a social media post, Gurman said Apple's celebrations will conclude this week with a finale at its Apple Park headquarters for employees.
A special...
Popular Stories
Apple is hoping to 3D-print aluminum device enclosures in the future, according to Bloomberg's Mark Gurman.
In today's "Power On" newsletter, Gurman revealed that Apple is pushing to move to 3D-printed aluminum enclosures for for future devices. The MacBook Neo relies on a new aluminum manufacturing process that saves as much metal as possible to drive down costs and speed up production....
Apple today launched its atrial fibrillation history feature for Apple Watch in mainland China.
Since 2022, Apple Watch in the U.S. has supported AFib History, which allows users diagnosed with atrial fibrillation to view an estimate of how frequently their heart is in this type of irregular rhythm.
The feature analyzes pulse rate data collected by a photoplethysmography (PPG) sensor to...
Apple's current blood oxygen sensing implementation in the U.S. does not infringe on patents owned by Masimo and Apple will not face a revived import ban, a U.S. International Trade Commission judge said this week (via Reuters).
After Apple was found to have violated Masimo's patents related to blood oxygen sensing, the Apple Watch faced a U.S. import ban that caused Apple to briefly pause...
